[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$sgmo

Sangamo Therapeutics ($SGMO) receives FDA Fast Track Designation for ST-503 for Small Fiber Neuropathy, adding to its Fabry Gene Therapy designation. Recent posts highlight strong short covering and anticipation of partnership news.

About $sgmo

SGMO is a biotechnology company focused on genomic medicine.

Insights

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX +61%
1-Year High: XXXXXXX on 2024-12-31
1-Year Low: XXXXX on 2025-12-06

Engagements by network (24h): X: XXXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX +58%
X Month: XXXXX +87%
X Months: XXXXX -XX%
X Year: XXXXXX +145%
1-Year High: XXX on 2025-01-02
1-Year Low: XX on 2025-05-25

Mentions by network (24h): X: XXXXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $sgmo in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XX
X Week: XXX +33%
X Month: XXX +225%
X Months: XXXXX +177%
X Year: XXXXX +164%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-05-25

The most influential creators that mention $sgmo in the last XX hours

Creator Rank Followers Posts Engagements
@Quantumup1 X XXXXX X XXXXX
@appalachiangabe X XXX X XXXXX
@BiotechAnalysst X XXXXX XX XXXXX
@Franca_ole X XXX X XXX
@yusufhameed X XXXXX X XXX
@traderMichael_1 X XXXXX X XXX
@truthdotphd X XXXXX X XXX
@Octopusking77 X XXXXX X XXX
@jmli19698 X XX X XXX
@L5l7sZYFAF59766 XX X X XXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% -X%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-05-19
1-Year Low: XX% on 2025-12-06

Most Supportive Themes:

Most Critical Themes:

Top $sgmo Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Truist $FULC's PT to $XX reiterated at a Buy and said 'Positive Reception Permeates Around Pociredir Deserving Of Greater Valuation Credit Post Cohort 4' $CRSP - VRTX PFE $AGIO NVO NVS EMMS Truist went on to say: Positive reception is persisting around the cohort X data from the ph.Ib PIONEER study for pociredir in SCD which came in as a win for FULC with robust efficacy shown in the way of the abs. HbF bar of XX% being hit in XX% of patients showing a clear dose-response over Cohort 3b's XX% of patients. A rapid treatment delta and supportive safety profile serve as additional support. We"
X Link @Quantumup1 2025-12-11T15:24Z 3928 followers, 1286 engagements

"#Fabry $SGMO These results show that classic enzymatic measurement underestimates mutations especially in women: "Fabry Disease: Incidence of the Common Later-Onset -Galactosidase A IVS4+919GA Mutation in Taiwanese NewbornsSuperiority of DNA-Based to Enzyme-Based Newborn Screening for Common Mutations""
X Link @Franca_ole 2025-12-11T12:33Z XXX followers, XXX engagements

"Don't miss out on real-time market updates Join my WhatsApp group We share daily stock trends and risk aversion strategies. We hand-pick quality stocks and provide real-time trading insights. Click here to join: $SGMO $ONDS $OPEN $ASST $FOXX"
X Link @traderMichael_1 2025-12-11T12:02Z 1813 followers, XXX engagements

"@nypost Devastating for this man and his family but there is hope - Sangamo Therapeutics $SGMO has developed a gene therapy that appears to be a functional cure for Fabry disease. It will be summited for FDA approval this year and may be available for patients by the end of 2026"
X Link @appalachiangabe 2025-12-10T23:53Z XXX followers, 5007 engagements